Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-024291
Filing Date
2013-04-26
Accepted
2013-04-26 16:12:49
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v342593_5.html 5  
1 OWNERSHIP DOCUMENT v342593_5.xml 5 4037
  Complete submission text file 0001144204-13-024291.txt   5397
Mailing Address 9700 GREAT SENECA HIGHWAY ROCKVILLE MD 20850
Business Address 9700 GREAT SENECA HIGHWAY ROCKVILLE MD 20850 3013664841
Neuralstem, Inc. (Issuer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10880 WILSHIRE BLVD SUITE 950 LOS ANGELES CA 90024
Business Address
OGILVIE SCOTT VARDE (Reporting) CIK: 0001379413 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-33672 | Film No.: 13787523